Future Developments in the Treatment of AL Amyloidosis

Future Developments in the Treatment of AL Amyloidosis

The treatment of AL amyloidosis has evolved, and outcomes have improved, but primarily for patients with low or intermediate-risk disease. Recent advances have been limited to improvements in anti-clonal therapies, which, alone, cannot change the poor prognosis of patients with high-risk disease. Th...

Bibliografski detalji
Glavni autori:	Foteini Theodorakakou, Despina Fotiou, Meletios A. Dimopoulos, Efstathios Kastritis
Format:	Članak
Jezik:	English
Izdano:	MDPI AG 2022-02-01
Serija:	Hemato
Teme:	amyloidosis non-transplant chemoimmunotherapy in AL amyloidosis amyloid-fibril targeting therapy in AL amyloidosis
Online pristup:	https://www.mdpi.com/2673-6357/3/1/12

Slični predmeti

Do Not Ignore Those Raccoon Eyes; They May Indicate Lethal AL Amyloidosis
od: Surendra Sapkota, i dr.
Izdano: (2022-11-01)

AL Amyloidosis
od: Desport Estelle, i dr.
Izdano: (2012-08-01)

Extensive Amyloid Purpura: An Unusual Presentation of Myeloma-associated Light Chain Amyloidosis
od: Nor Fazil Jaber, i dr.
Izdano: (2023-06-01)

Difficulties in diagnosis of primary AL-amyloidosis
od: V. A. Khyshova, i dr.
Izdano: (2021-09-01)

Kidney-limited AL amyloidosis: a case report and review of the literature
od: Sara Velayati, i dr.
Izdano: (2021-09-01)

Hemostasis disorders in patients with systemic AL-amyloidosis
od: Irina G. Rekhtina, i dr.
Izdano: (2023-11-01)

AMYLOIDOSIS HEART IN ELDERLY
od: L. I. Dvoretsky, i dr.
Izdano: (2015-12-01)

Review Article of Cardiac Amyloidosis
od: Jittiporn PURATTANAMAL
Izdano: (2011-11-01)

Biopsy Evidence of Sequential Transthyretin and Immunoglobulin Light-Chain Cardiac Amyloidosis in the Same Patient
od: Giuseppe Vergaro, MD, PhD, i dr.
Izdano: (2021-03-01)

Retinitis pigmentosa associated with systemic light chain amyloidosis (AL amyloidosis)
od: Salem Bouomrani, i dr.
Izdano: (2021-04-01)

Systemic amyloidosis journey from diagnosis to outcomes: a twelve-year real-world experience of a single center in a middle-income country
od: Roberta Shcolnik Szor, i dr.
Izdano: (2022-12-01)

Diagnostic problems of rare diseases - amyloidosis. A case report
od: Hanna Senat, i dr.
Izdano: (2024-02-01)

The Amyloidosis Forum: a public private partnership to advance drug development in AL amyloidosis
od: The Inaugural Amyloidosis Forum Panelists, i dr.
Izdano: (2020-09-01)

Multidisciplinary amyloidosis care in the era of personalized medicine
od: Naresh Bumma, i dr.
Izdano: (2022-10-01)

Cardiorenal links in systemic amyloidosis
od: V V Rameev, i dr.
Izdano: (2013-06-01)

Clinical observation of a combination of diffuse alveolar-septal pulmonary lesion and amyloid cardiomyopathy in systemic AL-amyloidosis in the elderly
od: A Yu Tret'yakov, i dr.
Izdano: (2018-12-01)

AL Amyloidosis for the Cardiologist and Oncologist
od: Ronald M. Witteles, MD, i dr.
Izdano: (2019-09-01)

Cardiac Amyloidosis: Clinical Features, Pathogenesis, Diagnosis, and Treatment
od: Asuman ARGON, i dr.
Izdano: (2024-01-01)

A rare case of systemic AL-amyloidosis under the mask of myocardial infarction in the absence of myocardial hypertrophy: case report
od: Svetlana A. Boldueva, i dr.
Izdano: (2022-12-01)

Amyloid and amyloidosis /
od: Skinner, Martha, i dr.
Izdano: (2005)

Is renal amyloidosis uncommon in Egypt? A-25-year study
od: Amal Labib, i dr.
Izdano: (2019-01-01)

Tissue Characterization in Cardiac Amyloidosis
od: Veronica Musetti, i dr.
Izdano: (2022-11-01)

Treatment Options For Relapsed/refractory Systemic Light-Chain (AL) Amyloidosis: Current Perspectives
od: Sarosiek S, i dr.
Izdano: (2019-10-01)

A case series of patients with cardiac amyloidosis evaluated at a Colombian university hospital
od: Juan David López-Ponce de León, i dr.
Izdano: (2025-02-01)

Editorial: Proceedings and predictions in cardiac amyloidosis: unsolved mysteries and challenges for the future
od: Aldostefano Porcari, i dr.
Izdano: (2023-07-01)

Evaluation of multinodular goiter and primary hyperparathyroidism leads to a diagnosis of AL amyloidosis
od: Chandani Patel Chavez, i dr.
Izdano: (2022-04-01)

Severe cardiac AL amyloidosis in an elderly patient with multiple SARS-CoV-2 reinfection: a case report
od: E. V. Reznik, i dr.
Izdano: (2023-09-01)

Massive splenic calcification in amyloidosis with normal labs and physical exam
od: Gaurav Dhansukhlal Gheewala, i dr.
Izdano: (2019-03-01)

Alterations of the gut microbiota in patients with immunoglobulin light chain amyloidosis
od: Jipeng Yan, i dr.
Izdano: (2022-10-01)

Research trends and hotspots evolution of cardiac amyloidosis: a bibliometric analysis from 2000 to 2022
od: Zhenyue Fu, i dr.
Izdano: (2023-02-01)

Cardiac amyloidosis is not a single disease: a multiparametric comparison between the light chain and transthyretin forms
od: Gabriela Neculae, i dr.
Izdano: (2024-10-01)

Cardiac amyloidosis
od: Gnana Deepthi Medarametla, i dr.
Izdano: (2023-08-01)

Primary localized amyloidosis of urinary bladder : A case report
od: Anil Kumar Goswami, i dr.
Izdano: (2002-01-01)

The utility of splenic imaging parameters in cardiac magnetic resonance for the diagnosis of immunoglobulin light-chain amyloidosis
od: Niki Lama, i dr.
Izdano: (2022-03-01)

Prevalence of Cardiac Amyloidosis in Patients Undergoing Echocardiography at a Tertiary Center
od: Jonathan D. Knott, MD, i dr.
Izdano: (2025-03-01)

A Case of Primary Amyloidosis Involving Liver, Stomach, Intestines, and Heart without Evident Kidney Involvement
od: L. S. Kholopov, i dr.
Izdano: (2022-03-01)

Cardiac Amyloidosis Therapy: A Systematic Review
od: Franco Iodice, i dr.
Izdano: (2021-01-01)

Nodular Cutaneous Amyloidosis at the Temple
od: Kathrin Schucht, i dr.
Izdano: (2016-07-01)

Significance of Oligomeric and Fibrillar Species in Amyloidosis: Insights into Pathophysiology and Treatment
od: Haruki Koike, i dr.
Izdano: (2021-08-01)

AL Amyloidosis and Multiple Myeloma: A Complex Scenario in Which Cardiac Involvement Remains the Key Prognostic Factor
od: Rafael Ríos-Tamayo, i dr.
Izdano: (2023-07-01)